NCT06813027View on ClinicalTrials.gov

Use of Allogeneic Extracellular Secretomes (EV)Derived From Umbilical Cord Mesenchymal Stromal Cells: a Phase I Open-label Safety Trial.

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

January 30, 2026

Study Completion Date

January 30, 2027

Conditions
Vitiligo
Interventions
BIOLOGICAL

EV

"Extracellular secretomes ( extracellular vesicles EV) derived from mesenchymal stroma cells (MSCs)"

Trial Locations (1)

00962

Cell Therapy Center, Amman

All Listed Sponsors
collaborator

Abdalla Awidi Abbadi, MD

UNKNOWN

lead

University of Jordan

OTHER